NEWS

February 20, 2017

Smaller finance firms rise to fill gaps in Stamford

February 3, 2017

Portola Pharmaceuticals Signs $150 Million Royalty Agreement with HealthCare Royalty Partners for Development and Commercialization of Andexanet Alfa

January 27, 2017

HealthCare Royalty Partners Announces New Chief Medical Officer, Senior-Level Promotions, and Further Regional Expansion

December 21, 2016

XOMA Announces up to $22 Million Generated from Sale of Royalty Streams from Two License Agreements to HealthCare Royalty Partners and Provides Corporate Update

December 12, 2016

Grünenthal to acquire commercialization rights of Qutenza® in Europe from Astellas Pharma Europe

November 7, 2016

Progenics Announces $50 Million RELISTOR® Royalty-Backed Financing

September 29, 2016

Stereotaxis Completes Private Placement of $24 Million

September 12, 2016

Horizon Pharma plc to Acquire Raptor Pharmaceutical Corp. as Further Step in Building Leading Rare Disease Business

September 9, 2016

AcuFocus Raises $66 Million in New Financing Round Led by KKR

August 28, 2016

Dealmaking in 2016: It’s Complicated